gefitinib, erlotinib / Apoptosis Cancer Research Results

GB, gefitinib, erlotinib: Click to Expand ⟱
Features:
selectively targeting the mutant proteins in malignant cells.
epidermal growth factor receptor (EGFR) inhibitors (lung cancer)


Apoptosis, Apoptosis: Click to Expand ⟱
Source:
Type: type of cell death
Situation in which a cell actively pursues a course toward death upon receiving certain stimuli.
Cancer is one of the scenarios where too little apoptosis occurs, resulting in malignant cells that will not die.


Scientific Papers found: Click to Expand⟱
6684- DAP,  GB,    Pharmacological synergism of 2,2-dichloroacetophenone and EGFR-TKi to overcome TKi-induced resistance in NSCLC cells
- vitro+vivo, NSCLC, H1975
PDK1↓, eff↑, EGFR↓, Apoptosis↑,
818- GAR,  GB,    Garcinol Sensitizes NSCLC Cells to Standard Therapies by Regulating EMT-Modulating miRNAs
- in-vitro, Lung, A549
miR-205↑, Let-7↑, Apoptosis↑, miR-200b↑, miR-218↑,

Showing Research Papers: 1 to 2 of 2

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2

Pathway results for Effect on Cancer / Diseased Cells:


Core Metabolism/Glycolysis(tgid=4)

PDK1↓, 1,  

Cell Death(tgid=5)

Apoptosis↑, 2,  

Transcription & Epigenetics(tgid=7)

miR-205↑, 1,   miR-218↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12)

Let-7↑, 1,  

Migration(tgid=13)

miR-200b↑, 1,  

Angiogenesis & Vasculature(tgid=14)

EGFR↓, 1,  

Drug Metabolism & Resistance(tgid=21)

eff↑, 1,  

Clinical Biomarkers(tgid=22)

EGFR↓, 1,  
Total Targets: 9

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: Apoptosis, Apoptosis
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:7  Target#:14  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page